highly significantp = 2.5 × 10 −8
The frequency of APOE ε4 carriers increased progressively across the clinical spectrum, from CN individuals (25%) to those with MCI (53%) and AD (71%), with a highly significant group effect ( p = 2.5 × 10 −8 ). 3.1.